Display options
Share it on

Iran J Basic Med Sci. 2014 Mar;17(3):209-15.

Permanent lesion in rostral ventromedial medulla potentiates swim stress-induced analgesia in formalin test.

Iranian journal of basic medical sciences

Ali Shamsizadeh, Neda Soliemani, Mohammad Mohammad-Zadeh, Hassan Azhdari-Zarmehri

Affiliations

  1. Physiology-Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  2. Department of Physiology & Pharmacology, Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  3. Department of Basic Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.

PMID: 24847424 PMCID: PMC4016692

Abstract

OBJECTIVE(S): There are many reports about the role of rostral ventromedial medulla (RVM) in modulating stress-induced analgesia (SIA). In the previous study we demonstrated that temporal inactivation of RVM by lidocaine potentiated stress-induced analgesia. In this study, we investigated the effect of permanent lesion of the RVM on SIA by using formalin test as a model of acute inflammatory pain.

MATERIALS AND METHODS: Three sets of experiments were conducted: (1) Application of stress protocol (2) Formalin injection after exposing the animals to the swim stress (3) Either the relevant vehicle or dopamine receptor 1 (D1) agonist R-SKF38393 was injected into the RVM to cause a lesion. For permanent lesion of RVM, R-SKF38393 was injected into the RVM. Forced swim stress in water was employed in adult male rats. Nociceptive responses were measured by formalin test (50µl injection of formalin 2% subcutaneously into hind paw) and pain related behaviors were monitored for 90 min.

RESULTS: In the unstressed rats, permanent lesion of the RVM by R-SKF38393 decreased formalin-induced nociceptive behaviors in phase 1, while in stressed rats, injection of R-SKF38393 into the RVM potentiated swim stress-induced antinociception in phase 1 and interphase, phase 2A of formalin test. Furthermore, R-SKF38393 had pronociceptive effects in phase2B whereas injections of R-SKF38393 resulted in significant difference in nociceptive bahaviours in all phases of formalin test (P<0.05).

CONCLUSION: The result of the present study demonstrated that permanent inactivation of RVM can potentiate stress-induced analgesia in formalin test.

Keywords: Analgesia; Formalin test; Inactivation; Lesion; Rostral ventromedial medulla; Swim stress

References

  1. Pain. 1976 Dec;2(4):379-404 - PubMed
  2. Neuroscience. 2010 Sep 1;169(3):1414-20 - PubMed
  3. Brain Res. 2003 Mar 7;965(1-2):259-68 - PubMed
  4. Neuroscience. 1998 Nov;87(1):123-33 - PubMed
  5. Eur J Neurosci. 1994 Aug 1;6(8):1328-34 - PubMed
  6. Brain Res. 1990 Nov 5;532(1-2):342-6 - PubMed
  7. Pharmacol Biochem Behav. 2012 Dec;103(2):299-307 - PubMed
  8. Pain. 1992 Oct;51(1):5-17 - PubMed
  9. Pharmacol Biochem Behav. 2011 May;98(3):417-24 - PubMed
  10. J Neurochem. 1992 Apr;58(4):1464-8 - PubMed
  11. Pharmacol Biochem Behav. 1993 Nov;46(3):661-6 - PubMed
  12. Brain Res. 1983 Oct 16;276(2):305-15 - PubMed
  13. J Neurophysiol. 2000 Jul;84(1):75-87 - PubMed
  14. J Neurosci. 1998 Nov 15;18(22):9453-70 - PubMed
  15. J Neurosci. 2002 Jun 15;22(12):5129-36 - PubMed
  16. Prog Neurobiol. 2009 Jul;88(3):184-202 - PubMed
  17. J Pain. 2011 Feb;12(2):280-7 - PubMed
  18. Neuroscience. 2005;134(1):269-81 - PubMed
  19. Prog Neurobiol. 2002 Apr;66(6):355-474 - PubMed
  20. Science. 1982 Jun 11;216(4551):1185-92 - PubMed
  21. Trends Neurosci. 2002 Jun;25(6):319-25 - PubMed
  22. Pain. 2004 Jul;110(1-2):158-65 - PubMed
  23. Neuroscience. 1992;48(3):533-43 - PubMed
  24. Anesth Prog. 2008 Summer;55(2):40-8 - PubMed
  25. Pharmacol Biochem Behav. 1984 Nov;21(5):813-6 - PubMed
  26. Behav Pharmacol. 2007 Nov;18(7):667-72 - PubMed
  27. J Pain. 2010 Apr;11(4):378-87 - PubMed
  28. Somatosens Mot Res. 1990;7(2):185-203 - PubMed
  29. Neurosci Lett. 2001 Dec 4;316(1):33-6 - PubMed
  30. Brain Res Dev Brain Res. 2000 Apr 14;120(2):191-8 - PubMed
  31. Science. 1977 Sep 30;197(4311):1367-9 - PubMed
  32. J Neurosci. 1994 Nov;14(11 Pt 2):7099-108 - PubMed
  33. Physiol Rev. 1986 Oct;66(4):1091-120 - PubMed
  34. Philos Trans R Soc Lond B Biol Sci. 1985 Feb 19;308(1136):361-74 - PubMed
  35. Pain. 2008 Nov 30;140(2):376-386 - PubMed
  36. Brain Res. 2012 Apr 23;1450:80-6 - PubMed
  37. Pharmacol Biochem Behav. 1993 Jun;45(2):299-304 - PubMed
  38. Pharmacol Biochem Behav. 1994 Mar;47(3):727-33 - PubMed
  39. Brain Res. 1986 Feb 26;366(1-2):203-10 - PubMed
  40. Pain. 1999 Dec;83(3):427-431 - PubMed
  41. Neurosci Biobehav Rev. 1980 Spring;4(1):87-100 - PubMed
  42. Pharmacol Biochem Behav. 2002 Sep;73(2):429-37 - PubMed
  43. J Neurosci. 2001 Jan 1;21(1):279-86 - PubMed
  44. Pain. 2004 Dec;112(3):361-371 - PubMed
  45. Science. 1980 May 9;208(4444):623-5 - PubMed
  46. Brain Res. 1990 Dec 3;535(1):155-8 - PubMed
  47. Nature. 1977 Jan 27;265(5592):358-60 - PubMed
  48. Brain Res. 2000 Jul 28;872(1-2):276-81 - PubMed
  49. Neuroscience. 1994 Nov;63(2):533-46 - PubMed
  50. Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7687-92 - PubMed
  51. Pain. 2010 Aug;150(2):358-368 - PubMed
  52. Pharmacol Biochem Behav. 1988 Jan;29(1):163-8 - PubMed
  53. Cell J. 2014 Summer;16(2):131-40 - PubMed
  54. Somatosens Mot Res. 1989;6(4):427-39 - PubMed
  55. J Neurophysiol. 2004 Oct;92(4):1982-9 - PubMed
  56. J Neurophysiol. 2006 Jan;95(1):33-41 - PubMed
  57. Ann N Y Acad Sci. 1986;467:273-99 - PubMed
  58. Physiol Behav. 1998 Jun 1;64(3):219-25 - PubMed

Publication Types